New research suggests that AIDS therapy should be initiated at higher CD4 levels than current guidelines recommend. In the study, published in the Sept. 15 issue of The Journal of Infectious Diseases, researchers wanted to reevaluate the optimal time to initiate highly active antiretroviral therapy (HAART).
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content